Unknown

Dataset Information

0

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.


ABSTRACT:

Rationale

In experimental models, lung fibrosis is dependent on transforming growth factor (TGF)-beta signaling. TGF-beta is secreted in a latent complex with its propeptide, and TGF-beta activators release TGF-beta from this complex. Because the integrin alpha(v)beta6 is a major TGF-beta activator in the lung, inhibition of alpha(v)beta6-mediated TGF-beta activation is a logical strategy to treat lung fibrosis.

Objectives

To determine, by genetic and pharmacologic approaches, whether murine radiation-induced lung fibrosis is dependent on alpha(v)beta6.

Methods

Wild-type mice, alpha(v)beta6-deficient (Itgb6-/-) mice, and mice heterozygous for a Tgfb1 mutation that eliminates integrin-mediated activation (Tgfb1(+/RGE)) were exposed to 14 Gy thoracic radiation. Some mice were treated with an anti-alpha(v)beta6 monoclonal antibody or a soluble TGF-beta receptor fusion protein. Alpha(v)beta6 expression was determined by immunohistochemistry. Fibrosis, inflammation, and gene expression patterns were assessed 20-32 weeks postirradiation.

Measurements and main results

Beta6 integrin expression increased within the alveolar epithelium 18 weeks postirradiation, just before onset of fibrosis. Itgb6-/- mice were completely protected from fibrosis, but not from late radiation-induced mortality. Anti-alpha(v)beta6 therapy (1-10 mg/kg/wk) prevented fibrosis, but only higher doses (6-10 mg/kg/wk) caused lung inflammation similar to that in Itgb6-/- mice. Tgfb1-haploinsufficient mice were also protected from fibrosis.

Conclusions

Alpha(v)beta6-mediated TGF-beta activation is required for radiation-induced lung fibrosis. Together with previous data, our results demonstrate a robust requirement for alpha(v)beta6 in distinct fibrosis models. Inhibition of alphavbeta6-mediated TGF-beta activation is a promising new approach for antifibrosis therapy.

SUBMITTER: Puthawala K 

PROVIDER: S-EPMC2176115 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.

Puthawala Khalid K   Hadjiangelis Nicos N   Jacoby Steven C SC   Bayongan Emmanuel E   Zhao Zhicheng Z   Yang Zhiwei Z   Devitt Mary Louise ML   Horan Gerald S GS   Weinreb Paul H PH   Lukashev Matvey E ME   Violette Shelia M SM   Grant Kristen S KS   Colarossi Cristina C   Formenti Silvia C SC   Munger John S JS  

American journal of respiratory and critical care medicine 20071004 1


<h4>Rationale</h4>In experimental models, lung fibrosis is dependent on transforming growth factor (TGF)-beta signaling. TGF-beta is secreted in a latent complex with its propeptide, and TGF-beta activators release TGF-beta from this complex. Because the integrin alpha(v)beta6 is a major TGF-beta activator in the lung, inhibition of alpha(v)beta6-mediated TGF-beta activation is a logical strategy to treat lung fibrosis.<h4>Objectives</h4>To determine, by genetic and pharmacologic approaches, whe  ...[more]

Similar Datasets

| S-EPMC1762706 | biostudies-literature
| S-EPMC2219547 | biostudies-literature
| S-EPMC3505071 | biostudies-literature
| S-EPMC2947271 | biostudies-literature
| S-EPMC4476448 | biostudies-literature
| S-EPMC3373641 | biostudies-literature
| S-EPMC2881917 | biostudies-literature
| S-EPMC2825738 | biostudies-literature
| S-EPMC10797247 | biostudies-literature
| S-EPMC5784400 | biostudies-literature